Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apyx Medical Co. stock logo
APYX
Apyx Medical
$1.48
-1.3%
$1.70
$1.21
$7.97
$51.27M1.09143,699 shs124 shs
Cytosorbents Co. stock logo
CTSO
Cytosorbents
$0.84
+2.2%
$0.94
$0.78
$4.29
$45.62M0.58154,597 shs2,523 shs
Neuronetics, Inc. stock logo
STIM
Neuronetics
$3.75
-2.8%
$3.90
$1.03
$5.07
$112.41M2.44126,990 shs20,642 shs
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
$67.16
-0.6%
$69.78
$66.17
$100.59
$241.04M0.1226,956 shs19,047 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apyx Medical Co. stock logo
APYX
Apyx Medical
+13.64%+13.64%+18.11%-34.50%-48.10%
Cytosorbents Co. stock logo
CTSO
Cytosorbents
-6.52%+4.01%-9.43%-6.96%-69.57%
Neuronetics, Inc. stock logo
STIM
Neuronetics
-2.85%-5.30%-20.38%+6.53%+68.16%
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
-0.59%-0.68%-3.16%-18.56%-28.58%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Apyx Medical Co. stock logo
APYX
Apyx Medical
3.808 of 5 stars
3.54.00.04.20.01.70.6
Cytosorbents Co. stock logo
CTSO
Cytosorbents
0.7195 of 5 stars
3.32.00.00.00.60.00.6
Neuronetics, Inc. stock logo
STIM
Neuronetics
1.2527 of 5 stars
3.33.00.00.00.01.70.6
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
3.1409 of 5 stars
0.05.01.74.22.11.71.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Apyx Medical Co. stock logo
APYX
Apyx Medical
3.00
Buy$6.17316.67% Upside
Cytosorbents Co. stock logo
CTSO
Cytosorbents
2.50
Moderate Buy$2.50197.62% Upside
Neuronetics, Inc. stock logo
STIM
Neuronetics
2.50
Moderate Buy$8.00113.33% Upside
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
N/AN/AN/AN/A

Current Analyst Ratings

Latest UTMD, APYX, CTSO, and STIM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/26/2024
Neuronetics, Inc. stock logo
STIM
Neuronetics
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
3/15/2024
Cytosorbents Co. stock logo
CTSO
Cytosorbents
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$1.00
3/6/2024
Neuronetics, Inc. stock logo
STIM
Neuronetics
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$7.00 ➝ $8.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Apyx Medical Co. stock logo
APYX
Apyx Medical
$52.35M0.98N/AN/A$0.78 per share1.90
Cytosorbents Co. stock logo
CTSO
Cytosorbents
$36.35M1.26N/AN/A$0.52 per share1.62
Neuronetics, Inc. stock logo
STIM
Neuronetics
$71.35M1.58N/AN/A$1.18 per share3.18
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
$50.22M4.80$6.30 per share10.66$35.35 per share1.90

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Apyx Medical Co. stock logo
APYX
Apyx Medical
-$18.71M-$0.54N/AN/AN/A-35.75%-54.90%-28.41%5/9/2024 (Estimated)
Cytosorbents Co. stock logo
CTSO
Cytosorbents
-$28.51M-$0.64N/AN/AN/A-78.43%-120.24%-54.11%5/7/2024 (Estimated)
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$30.19M-$1.07N/AN/AN/A-42.31%-72.76%-29.25%5/7/2024 (Confirmed)
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
$16.64M$4.5714.70N/A33.12%13.53%12.68%N/A

Latest UTMD, APYX, CTSO, and STIM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$0.33N/A+$0.33N/AN/AN/A  
3/21/2024Q4 2023
Apyx Medical Co. stock logo
APYX
Apyx Medical
-$0.13-$0.19-$0.06-$0.10$14.40 million$14.66 million
3/14/2024Q4 2023
Cytosorbents Co. stock logo
CTSO
Cytosorbents
-$0.14-$0.12+$0.02-$0.12$9.29 million$8.67 million
3/5/202412/31/2023
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$0.26-$0.19+$0.07-$0.19$19.73 million$20.31 million    
1/30/2024Q4 2023
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
N/A$1.18+$1.18$1.18N/A$12.33 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Apyx Medical Co. stock logo
APYX
Apyx Medical
N/AN/AN/AN/AN/A
Cytosorbents Co. stock logo
CTSO
Cytosorbents
N/AN/AN/AN/AN/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
N/AN/AN/AN/AN/A
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
$1.201.79%+1.75%26.26%2 Years

Latest UTMD, APYX, CTSO, and STIM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/6/2024
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
quarterly$0.301.6%3/14/20243/15/20244/3/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Apyx Medical Co. stock logo
APYX
Apyx Medical
1.23
5.52
4.74
Cytosorbents Co. stock logo
CTSO
Cytosorbents
0.11
1.77
1.51
Neuronetics, Inc. stock logo
STIM
Neuronetics
1.73
4.73
4.33
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
N/A
22.56
20.53

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Apyx Medical Co. stock logo
APYX
Apyx Medical
55.33%
Cytosorbents Co. stock logo
CTSO
Cytosorbents
32.87%
Neuronetics, Inc. stock logo
STIM
Neuronetics
53.59%
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
69.60%

Insider Ownership

CompanyInsider Ownership
Apyx Medical Co. stock logo
APYX
Apyx Medical
13.10%
Cytosorbents Co. stock logo
CTSO
Cytosorbents
8.10%
Neuronetics, Inc. stock logo
STIM
Neuronetics
9.80%
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
6.50%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Apyx Medical Co. stock logo
APYX
Apyx Medical
25234.64 million30.11 millionOptionable
Cytosorbents Co. stock logo
CTSO
Cytosorbents
18654.31 million49.91 millionOptionable
Neuronetics, Inc. stock logo
STIM
Neuronetics
20329.98 million27.04 millionOptionable
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
1693.59 million3.36 millionNot Optionable

UTMD, APYX, CTSO, and STIM Headlines

SourceHeadline
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2024Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2024
accesswire.com - April 25 at 9:00 AM
Utah mom fights for her daughter’s access to discontinued diabetes medication: ‘Life-savingUtah mom fights for her daughter’s access to discontinued diabetes medication: ‘Life-saving'
msn.com - April 19 at 7:30 AM
Fairmat opens first U.S. industrial facility in UtahFairmat opens first U.S. industrial facility in Utah
compositesworld.com - April 18 at 3:57 PM
Hurdles in Utah push medical cannabis patients toward out-of-state products.Hurdles in Utah push medical cannabis patients toward out-of-state products.
cityweekly.net - April 17 at 6:18 PM
Advance directives help people plan for their future medical care and quality of lifeAdvance directives help people plan for their future medical care and quality of life
msn.com - April 12 at 5:30 PM
2 Beaten-Down Stocks That Could Be Ready to Soar2 Beaten-Down Stocks That Could Be Ready to Soar
fool.com - April 11 at 5:33 AM
Utah Department of Agriculture unveils new analysis of Utahs Medical Cannabis marketUtah Department of Agriculture unveils new analysis of Utah's Medical Cannabis market
cachevalleydaily.com - April 9 at 4:39 PM
Intermountain Health’s Transplant Program and patients celebrate life-saving medical milestoneIntermountain Health’s Transplant Program and patients celebrate life-saving medical milestone
msn.com - March 14 at 10:05 PM
Utah at the forefront of Americas alarming prescription drug shortagesUtah at the forefront of America's alarming prescription drug shortages
ksl.com - March 12 at 6:37 PM
Utah at the forefront of America’s alarming prescription drug shortagesUtah at the forefront of America’s alarming prescription drug shortages
msn.com - March 11 at 9:12 PM
Utah Valleys 1st osteopathic college to host grand opening for innovative buildingUtah Valley's 1st osteopathic college to host grand opening for 'innovative' building
ksl.com - March 4 at 2:15 PM
Utah Medical Products, Inc.s (NASDAQ:UTMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?Utah Medical Products, Inc.'s (NASDAQ:UTMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
finance.yahoo.com - March 4 at 8:49 AM
Utah’s 2024 legislative session bookended by DEI, transgender issues and new baseball, hockey stadiumsUtah’s 2024 legislative session bookended by DEI, transgender issues and new baseball, hockey stadiums
msn.com - March 3 at 9:18 AM
Utah Medicaid to provide up to 30-day supply of medication at no cost amid cyber outageUtah Medicaid to provide up to 30-day supply of medication at no cost amid cyber outage
msn.com - February 25 at 2:35 PM
Utah affected by E. coli contamination in raw milk cheeseUtah affected by E. coli contamination in raw milk cheese
news.yahoo.com - February 18 at 2:20 PM
Utah Medical Products, Inc. Announces Quarterly DividendUtah Medical Products, Inc. Announces Quarterly Dividend
finance.yahoo.com - February 6 at 12:42 PM
Utah Medical Products Full Year 2023 Earnings: EPS: US$4.57 (vs US$4.53 in FY 2022)Utah Medical Products Full Year 2023 Earnings: EPS: US$4.57 (vs US$4.53 in FY 2022)
finance.yahoo.com - January 31 at 5:58 PM
Utah Medical Products, Inc.: UTMD Reports Audited Year 2023 and Fourth Quarter Financial PerformanceUtah Medical Products, Inc.: UTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance
finanznachrichten.de - January 30 at 7:07 PM
UTMD Reports Audited Year 2023 and Fourth Quarter Financial PerformanceUTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance
finance.yahoo.com - January 30 at 7:07 PM
Utah Medical Products Inc (UTMD) Reports Mixed 2023 Financial ResultsUtah Medical Products Inc (UTMD) Reports Mixed 2023 Financial Results
finance.yahoo.com - January 30 at 7:07 PM
Investors Could Be Concerned With Utah Medical Products (NASDAQ:UTMD) Returns On CapitalInvestors Could Be Concerned With Utah Medical Products' (NASDAQ:UTMD) Returns On Capital
finance.yahoo.com - January 26 at 11:24 AM
Big changes made to Utah’s controversial bathroom bill, but concerns remainBig changes made to Utah’s controversial bathroom bill, but concerns remain
yahoo.com - January 25 at 4:01 AM
Should cold plunge tubs be regulated in Utah? Here’s what a legislative committee decidedShould cold plunge tubs be regulated in Utah? Here’s what a legislative committee decided
msn.com - January 20 at 12:12 AM
The magic behind the high-impact discoveries from Utah’s universitiesThe magic behind the high-impact discoveries from Utah’s universities
news.yahoo.com - January 19 at 7:12 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Apyx Medical logo

Apyx Medical

NASDAQ:APYX
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets in the United States and internationally. It operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). The company offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. Its Helium Plasma Technology products are marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It also develops and manufactures hand pieces for open and laparoscopic procedures; and OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Cytosorbents logo

Cytosorbents

NASDAQ:CTSO
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.
Neuronetics logo

Neuronetics

NASDAQ:STIM
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Utah Medical Products logo

Utah Medical Products

NASDAQ:UTMD
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.